Rowley Elizabeth Ak, Mitchell Patrick K, Yang Duck-Hye, Lewis Ned, Dixon Brian E, Vazquez-Benitez Gabriela, Fadel William F, Essien Inih J, Naleway Allison L, Stenehjem Edward, Ong Toan C, Gaglani Manjusha, Natarajan Karthik, Embi Peter, Wiegand Ryan E, Link-Gelles Ruth, Tenforde Mark W, Fireman Bruce
Westat, Rockville, MD, United States.
Vaccine Study Center, Northern California Division of Research, Kaiser Permanente, Oakland, CA, United States.
JMIR Form Res. 2025 Jan 27;9:e58981. doi: 10.2196/58981.
Real-world COVID-19 vaccine effectiveness (VE) studies are investigating exposures of increasing complexity accounting for time since vaccination. These studies require methods that adjust for the confounding that arises when morbidities and demographics are associated with vaccination and the risk of outcome events. Methods based on propensity scores (PS) are well-suited to this when the exposure is dichotomous, but present challenges when the exposure is multinomial.
This simulation study aimed to investigate alternative methods to adjust for confounding in VE studies that have a test-negative design.
Adjustment for a disease risk score (DRS) is compared with multivariable logistic regression. Both stratification on the DRS and direct covariate adjustment of the DRS are examined. Multivariable logistic regression with all the covariates and with a limited subset of key covariates is considered. The performance of VE estimators is evaluated across a multinomial vaccination exposure in simulated datasets.
Bias in VE estimates from multivariable models ranged from -5.3% to 6.1% across 4 levels of vaccination. Standard errors of VE estimates were unbiased, and 95% coverage probabilities were attained in most scenarios. The lowest coverage in the multivariable scenarios was 93.7% (95% CI 92.2%-95.2%) and occurred in the multivariable model with key covariates, while the highest coverage in the multivariable scenarios was 95.3% (95% CI 94.0%-96.6%) and occurred in the multivariable model with all covariates. Bias in VE estimates from DRS-adjusted models was low, ranging from -2.2% to 4.2%. However, the DRS-adjusted models underestimated the standard errors of VE estimates, with coverage sometimes below the 95% level. The lowest coverage in the DRS scenarios was 87.8% (95% CI 85.8%-89.8%) and occurred in the direct adjustment for the DRS model. The highest coverage in the DRS scenarios was 94.8% (95% CI 93.4%-96.2%) and occurred in the model that stratified on DRS. Although variation in the performance of VE estimates occurred across modeling strategies, variation in performance was also present across exposure groups.
Overall, models using a DRS to adjust for confounding performed adequately but not as well as the multivariable models that adjusted for covariates individually.
现实世界中关于新冠病毒疫苗有效性(VE)的研究正在调查日益复杂的暴露情况,同时考虑自接种疫苗以来的时间因素。这些研究需要一些方法来调整因发病率和人口统计学特征与疫苗接种及结局事件风险相关联而产生的混杂因素。当暴露为二分变量时,基于倾向得分(PS)的方法非常适合,但当暴露为多项变量时则面临挑战。
本模拟研究旨在探究在具有检测阴性设计的VE研究中调整混杂因素的替代方法。
将疾病风险评分(DRS)调整方法与多变量逻辑回归进行比较。研究了DRS分层法和DRS直接协变量调整法。考虑了包含所有协变量以及仅包含关键协变量有限子集的多变量逻辑回归。在模拟数据集中,针对多项疫苗接种暴露情况评估VE估计量的性能。
在4个疫苗接种水平上,多变量模型的VE估计偏差范围为-5.3%至6.1%。VE估计的标准误无偏差,且在大多数情况下达到了95%的覆盖概率。多变量情况下最低的覆盖概率为93.7%(95%置信区间92.2%-95.2%),出现在包含关键协变量的多变量模型中;而最高的覆盖概率为95.3%(95%置信区间94.0%-96.6%),出现在包含所有协变量的多变量模型中。DRS调整模型的VE估计偏差较低,范围为-2.2%至4.2%。然而,DRS调整模型低估了VE估计的标准误,其覆盖概率有时低于95%水平。DRS情况下最低的覆盖概率为87.8%(95%置信区间85.8%-89.8%),出现在DRS模型的直接调整中;最高的覆盖概率为94.8%(95%置信区间93.4%-96.2%),出现在DRS分层模型中。尽管VE估计性能的差异在不同建模策略中均有出现,但在不同暴露组中也存在性能差异。
总体而言,使用DRS调整混杂因素的模型表现良好,但不如单独调整协变量的多变量模型。